Referral pulse and growth for heme/onc practices
Hematology practices often miss inbound referrals from PCPs and surgical specialties. Here’s how to measure and capture them.
Tag: primary specialty
AI tools for hematology: anticoagulation, peripheral smear, and CDS
Heme AI is moving fast in peripheral smear interpretation, anticoag dosing, and CDS. Here’s the tool directory.
Real estate for hematologists: the depreciation play for high-K-1 income
K-1 income from infusion practices shields differently than W-2. Here’s how real estate depreciation interacts with practice income.
Tax planning for hematologists with practice equity
If you’re a heme partner with K-1 income, the tax structure is different. Here’s the optimization for partnership-track hematologists.
Buy-and-bill economics for hematology: why PE is rolling up your specialty
Hematology infusion margins are why private equity has been acquiring heme/onc practices. Here’s the economics PE sees and how to evaluate a sale offer.
Hepatology subspecialty economics and CenterIQ liver procedure rates
Hepatology pays differently than general GI. Here’s the rate data for liver procedures and the practice structure considerations.
AI tools for gastroenterology: polyp detection, dictation, and CDS
GI AI has the most clinical-evidence weight of any specialty AI. Here’s the directory of tools with deployment data.
Real estate for gastroenterologists: ASC building + personal portfolio
GI ASC owners often own the building too. Here’s how to layer that with a personal real estate portfolio.
Tax planning for gastroenterologists: ASC equity changes the structure
If you have ASC K-1 income, your tax structure is different from a pure W-2 cardiologist. Here’s the optimization stack.
Endoscopy ASC ownership: the textbook gastroenterology equity story
GI endoscopy ASCs are the cleanest physician-equity story in medicine. Here’s the rate data, the proforma, and the path.